Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

M. Fedders; M. Hartmann; A. Schneider; R. Kath; O. Camara; H. Oelschl?ger

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

【24h】

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

机译：马尔可夫模型用于铂类药物和紫杉醇一线化疗以及托泊替康和脂质体阿霉素作为上皮卵巢癌的二线化疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2007年第12期|p 1025-p 1025|共1页
作者
M. Fedders; M. Hartmann; A. Schneider; R. Kath; O. Camara; H. Oelschl?ger;
展开▼
作者单位

Duisburg Hospital Zu den Rehwiesen 9 47055 Duisburg Germany;

FSU Hospital Pharmacy Erlanger Allee 101 07743 Jena Germany;

Hospital for Gynecology and Interdisciplinary Breast Center Charité Campus Mitte Charitéplatz 1 10117 Berlin Germany;

Clinic for Hematology and Oncology Medical Clinic I Hospitals Essen Nord-West Hülsmannstrasse 6 45355 Essen Germany;

Hospital for Gynecology FSU Jena Bachstrasse 18 07740 Jena Germany;

Institute for Pharmacy FSU Jena Semmelweissstrasse 10 07743 Jena Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma [J] . M. Hartmann, M. Fedders, A. Schneider, Journal of Cancer Research and Clinical Oncology . 2007,第9期

机译：马尔可夫模型用于铂类药物和紫杉醇一线化疗以及托泊替康和脂质体阿霉素作为上皮卵巢癌的二线化疗
2. COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN [J] . Huang H., Tang C., Cheng W., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：铂铂加紫杉醇，普至铂和台湾铂敏感患者二线化疗铂钙和脂质体多柔比星的比较效果
3. Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial [J] . Poveda Andres M., Selle Frederic, Hilpert Felix, Journal of Clinical Oncology . 2015,第32期

机译：贝伐单抗联合每周紫杉醇，聚乙二醇化的脂质体阿霉素或托泊替康治疗铂类耐药性复发性卵巢癌：随机III期AURELIA试验的化学治疗队列分析
4. Weekly Paclitaxel Therapy as the Second-line Chemotherapy to TS-1 for Advanced/Metastatic Gastric Cancer [C] . M. Fujishima, H. Imamura, H. Furukawa, International Gastric Cancer Congress . 2005

机译：每周紫杉醇治疗作为先进/转移性胃癌的二线化学疗法至TS-1
5. Chronic Neurobehavioral Stress Promotes Resistance to Chemotherapy in Epithelial Ovarian Carcinoma. [D] . Shahzad, Mian Mohammed Khuram. 2013

机译：慢性神经行为应激可促进上皮性卵巢癌对化学疗法的耐药性。
6. Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Müllerian Carcinoma (Epithelial Ovarian Carcinoma Primary Carcinoma of Fallopian Tube Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group [O] . Noriyuki Katsumata, Yasuhiro Fujiwara, Toshiharu Kamura, -1

机译：聚乙二醇化脂质体阿霉素（JNS002）在日本米勒癌（上皮性卵巢癌输卵管原发癌腹膜癌）患者中的铂类化学疗法的II期临床试验：日本妇科肿瘤学的II期研究组
7. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma [O] . M. Fedders, M. Hartmann, A. Schneider, 2007

机译：Markov-instrinaum类似物和紫杉醇作为一线化学疗法以及拓扑康和脂质体多柔比星作为二线化疗，具有上皮卵巢癌的二线化学疗法

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

著录项

相似文献

相关主题

期刊订阅